David L. Garver, MD
- 4Articles
- 7.4KReads1
- 2000–2002Active
- 2Collaborators
About
David L. Garver, MD, has published extensively on topics related to schizophrenia and schizoaffective disorders, neurology, and psychopharmacology. His work includes articles on clinical psychopharmacology essentials, variability in antipsychotic treatment responses across schizophrenia spectrum disorders, early psychosis recognition and management, and reviews of antipsychotic side effects such as those associated with quetiapine. Garver has collaborated frequently with James D. Christensen and Jennifer A. Holcomb. His contributions appeared in Psychiatrist.com between 2000 and 2002.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
